1. Home
  2. FFIC vs VNDA Comparison

FFIC vs VNDA Comparison

Compare FFIC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flushing Financial Corporation

FFIC

Flushing Financial Corporation

HOLD

Current Price

$14.96

Market Cap

536.1M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$8.61

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIC
VNDA
Founded
1929
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.1M
474.0M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
FFIC
VNDA
Price
$14.96
$8.61
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$16.80
$14.90
AVG Volume (30 Days)
175.2K
3.4M
Earning Date
04-28-2026
01-01-0001
Dividend Yield
5.85%
N/A
EPS Growth
151.43
N/A
EPS
0.54
N/A
Revenue
$7,455,000.00
$216,105,000.00
Revenue This Year
$14.57
$21.50
Revenue Next Year
$6.64
$38.67
P/E Ratio
$27.74
N/A
Revenue Growth
7.31
8.72
52 Week Low
$10.65
$3.81
52 Week High
$17.79
$9.91

Technical Indicators

Market Signals
Indicator
FFIC
VNDA
Relative Strength Index (RSI) 35.58 54.51
Support Level $14.44 $7.39
Resistance Level $15.57 $9.53
Average True Range (ATR) 0.40 0.54
MACD -0.09 0.04
Stochastic Oscillator 6.36 41.58

Price Performance

Historical Comparison
FFIC
VNDA

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: